DeepMed Research

University Of Southampton

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 1862-01-01

Employees: -

Market Cap: -

Website: https://southampton.ac.uk/

Clinical Trials

Safety and Tolerability of Etanercept in Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Other: Placebo
Biological: Etanercept

First Posted Date: 2010-02-12

Last Posted Date: 2014-04-23

Lead Sponsor: University of Southampton

Target Recruit Count: 41

Registration Number: NCT01068353

Locations: 🇬🇧
Memory Assessment and Research Centre, Moorgreen Hospital, Southampton, Hampshire, United Kingdom

An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Seretide 500 Accuhaler

First Posted Date: 2009-09-10

Last Posted Date: 2014-12-08

Lead Sponsor: University of Southampton

Target Recruit Count: 48

Registration Number: NCT00974805

Locations: 🇬🇧
Southampton General Hospital, Southampton, Hampshire, United Kingdom

A Trial of Booklet Based Self Management of Dizziness

Not Applicable

Completed

Conditions: Dizziness

Interventions: Behavioral: Self-treatment booklet
Behavioral: Remote telephone support

First Posted Date: 2008-08-12

Last Posted Date: 2022-01-18

Lead Sponsor: University of Southampton

Target Recruit Count: 337

Registration Number: NCT00732797

Locations: 🇬🇧
Hampshire PCT and Berkshire PCT, Southampton, United Kingdom

Simplified Nutritional Screening for Patient Use

Conditions: Malnutrition

First Posted Date: 2008-07-14

Last Posted Date: 2009-01-05

Lead Sponsor: University of Southampton

Target Recruit Count: 2200

Registration Number: NCT00714324

Locations: 🇬🇧
Southampton University Hospitals NHS trust, Southampton, Hampshire, United Kingdom

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

Phase 2

Terminated

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

Interventions: Drug: melphalan
Procedure: autologous hematopoietic stem cell transplantation
Radiation: yttrium Y 90 anti-CD66 monoclonal antibody BW 250/183

First Posted Date: 2008-03-18

Last Posted Date: 2020-12-23

Lead Sponsor: University of Southampton

Target Recruit Count: 25

Registration Number: NCT00637767

Locations: 🇬🇧
Southampton General Hospital, Southampton, England, United Kingdom
🇬🇧
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
🇬🇧
Saint Bartholomew's Hospital, London, England, United Kingdom

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

Phase 2

Terminated

Conditions: Lymphoma

Interventions: Biological: rituximab
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: prednisolone
Drug: vincristine sulfate
Radiation: yttrium Y 90 ibritumomab tiuxetan

First Posted Date: 2008-03-18

Last Posted Date: 2022-01-06

Lead Sponsor: University of Southampton

Target Recruit Count: 1

Registration Number: NCT00637832

Locations: 🇬🇧
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom
🇬🇧
Dorset Cancer Centre, Poole Dorset, England, United Kingdom
🇬🇧
Southampton General Hospital, Southampton, England, United Kingdom

and more 2 locations

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Phase 1

Conditions: Brain and Central Nervous System Tumors
Extragonadal Germ Cell Tumor
Ovarian Cancer
Testicular Germ Cell Tumor

Interventions: Biological: filgrastim
Biological: lenograstim
Biological: pegfilgrastim
Drug: cisplatin
Drug: gemcitabine hydrochloride
Drug: ifosfamide
Drug: paclitaxel

First Posted Date: 2007-10-30

Last Posted Date: 2013-01-23

Lead Sponsor: University of Southampton

Target Recruit Count: 23

Registration Number: NCT00551122

Locations: 🇬🇧
Southampton General Hospital, Southampton, England, United Kingdom
🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom
🇬🇧
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom

Chronic Obstructive Pulmonary Disease (COPD) Nutrition Support Trial

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Other: Dietary Advice
Dietary Supplement: Oral Nutritional Supplements (Fortisip)

First Posted Date: 2007-10-02

Last Posted Date: 2014-12-08

Lead Sponsor: University of Southampton

Target Recruit Count: 85

Registration Number: NCT00538200

Locations: 🇬🇧
Southampton University Hospitals NHS Trust, Southampton, Hampshire, United Kingdom

The Role of Biofeedback in Improving Continence After Anterior Resection

Not Applicable

Completed

Conditions: Rectal Neoplasms
Fecal Incontinence
Aged

Interventions: Behavioral: Biofeedback

First Posted Date: 2007-08-14

Last Posted Date: 2022-03-07

Lead Sponsor: University of Southampton

Target Recruit Count: 121

Registration Number: NCT00515853

Locations: 🇬🇧
Southampton General Hospital, Southampton, Hampshire, United Kingdom

Community Oral Nutrition Support Trial

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Dietary Supplement: Oral Nutritional Supplements (Fortisip)
Behavioral: Dietary Advice

First Posted Date: 2007-08-13

Last Posted Date: 2015-09-11

Lead Sponsor: University of Southampton

Target Recruit Count: 104

Registration Number: NCT00515125

Locations: 🇬🇧
Care Homes in Hampshire, Southampton, Hampshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy